McLean, VA – March 24, 2021 – The Direct Selling Self-Regulatory Council (DSSRC) of BBB National Programs referred certain product performance claims for the Primocyn product line, made by UWell Life, Inc. and its salesforce members, to the Federal Trade Commission (FTC) for possible enforcement action after UWell Life failed to provide substantiation for the claims.
At issue in DSSRC’s inquiry are product performance claims made on the Primocyn product website and disseminated by salesforce members on social media implying that Primocyn products can prevent and/or treat several serious health-related conditions, including COVID-19. In addition, UWell Life salesforce members implied that Primocyn products have been approved by the FDA.
UWell Life is a direct selling company that offers nutrients, essential vitamins, and other wellness products including Primocyn branded products. The following claims were brought to UWell Life’s attention by the DSSRC as part of its ongoing independent monitoring of the direct selling marketplace.
See original story at bbbprograms.org